Vivani Medical, Inc. announced a registered direct offering of 6,000,000 shares of common stock at $1.62 per share, along with a private placement of 3,703,703 shares at the same price, expected to raise $15.7 million. The proceeds will fund research, clinical development, and general corporate purposes. ThinkEquity is the sole placement agent. The offering will be made under a shelf registration statement. Vivani develops drug implants using NanoPortal™ platform for steady drug delivery over time, focusing on metabolic diseases. Forward-looking statements caution about uncertainties and risks. For more information, visit www.vivani.com.

Read more at GlobeNewswire: Vivani Medical, Inc. Announces Pricing of Common Stock